TOS for penicillin resistant gonorrhoea
**Core Concept**
Penicillin-resistant gonorrhea is a significant public health concern, and the treatment of choice needs to be updated accordingly. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) recommend alternative antibiotics for the treatment of penicillin-resistant gonorrhea.
**Why the Correct Answer is Right**
The recommended treatment for penicillin-resistant gonorrhea is dual therapy with ceftriaxone and azithromycin. Ceftriaxone is a third-generation cephalosporin antibiotic that has a broad spectrum of activity against Neisseria gonorrhoeae, including penicillin-resistant strains. Azithromycin is a macrolide antibiotic that provides additional coverage against gonorrhea and helps to prevent the development of resistance to ceftriaxone. The combination of these two antibiotics has been shown to be highly effective in treating penicillin-resistant gonorrhea.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because ciprofloxacin is no longer recommended for the treatment of gonorrhea due to widespread resistance.
**Option B:** This option is incorrect because cefixime is a monotherapy that may not be effective against all strains of penicillin-resistant gonorrhea.
**Option C:** This option is incorrect because doxycycline is not recommended as a first-line treatment for gonorrhea due to its lower efficacy compared to other antibiotics.
**Option D:** This option is incorrect because levofloxacin is not recommended for the treatment of gonorrhea due to high rates of resistance.
**Clinical Pearl / High-Yield Fact**
Remember that the treatment of penicillin-resistant gonorrhea requires a combination of antibiotics to prevent the development of resistance. Always check the latest guidelines from the CDC and WHO for the most up-to-date recommendations.
**Correct Answer: C. Ceftriaxone and azithromycin**